Catalyst Wire Dossier Catalyst Wire Dossier

VASOPRESSIN IN 0.9% SODIUM CHLORIDE

vasopressin · Long Grove Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VASOPRESSIN IN 0.9% SODIUM CHLORIDE, covering 2023-09-29 to 2025-02-21. Get the full timeline:

Most recent: FDA Approved: VASOPRESSIN IN 0.9% SODIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)

See pricing